Navigation Links
New Tools for Making and Processing Protein Microarrays.

By Linda E. Cammish, Ph.D., NextGen Sciences, Ltd. and Mark N. Bobrow, Ph.D., PerkinElmer Life Sciences, Inc.

Introduction

The use of DNA microarrays in scientific research and drug discovery has become very widespread. However, since it is proteins and not genes that are the vast majority of the true drug targets, there has been a fast growing interest in the use of functional protein microarrays, sometimes referred to as protein biochips. Unlike DNA molecules, functional proteins are not as easy to attach to a biochip substrate. Proteins also exhibit a wider range of physical characteristics, these being determined by the charged or non-charged functional side groups, regions of hydrophobicity or hydrophilicity and the manner in which the protein is folded via covalent or non-covalent interactions.

The production of protein microarrays is therefore fraught with many more problems than those encountered in the use of DNA microarrays. In addition, the use of protein microarrays requires that the assays performed be highly optimized due to the fact that there are many more variables to deal with including different pH conditions, buffer compositions, detergent types and concentrations, blocking reagents to prevent non-specific interactions and also the way in which the proteins are attached to substrates. All of these parameters have a significant impact on the affinity and specificity of protein-protein or protein-ligand interactions.

Despite these challenges, multiple protein assays that are performed in parallel, in miniature and in the format of a protein array hold great potential for target discovery and validation. To support this development process, there is a growing need to be able to automate these assays to improve sensitivity and reproducibility, and to make the optimization of each assay quicker and easier for the researcher to perform. To achieve
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Tools for Detecting MSH2 Expression in Chinese Hamster Ovary Cells
2. Tools for Proteomic Science II
3. Gene Expression Arrays: Highly Sensitive Detection of Expression Patterns with Improved Tools for Target Amplification
4. New Tools for Small RNA Analysis
5. Research Tools for Analysis of ZAP-70
6. SNPs Powerful Tools for Association Studies
7. RNAlater Around the World: The Art of Processing Difficult Samples
8. A New C-Terminal GST Vector for Protein Production in S. pombe
9. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
10. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
11. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Tools for Making and Processing Protein Microarrays

(Date:11/6/2009)..., Nov. 6 ,, 3Q09 C...f Qutenza(TM) E.U. Marketing Authorization to Aste...s in commercial readiness activities Expanded man... Marketing; and Director, Commercial Operations A...and Audit Committee chairman , Upcoming 200...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personali... to take place on February 22-24, 2010 in Philadel...ence we will highlight key issues in forming partn...r experiences. , Minneapo... Arrowhead’s 2010 Personalized Medicine Par...
(Date:11/5/2009)... Nov. 5 DSM Pharmaceutical Product... alliance with Galenix, Saint Jean D,Illac, France... manufacturing partner for Galenix commercial prod... collaborate on business development opportunities...based on the strength of Galenix in drug product d...
(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
... /PRNewswire-FirstCall/ - Spectral Diagnostics Inc...its relationship with Toray,Medical Co. Ltd. for t...vity Assay (EAA(TM)), the only FDA cleared assay f...f the new collaboration agreement, Spectral,will h...ic territories,including China, India, Russia and ...
...artners with Bioscene in Japan - Expands Presence ...Xennex) announced,today that the Japan Patent Offi...nounced that it has selected Bioscene Informatics ...istribution of GeneCards in Japan., GeneCards wil...approval,of patent applications in the life scienc...
...N, May 5 /PRNewswire-FirstCall/ - YM BioSciences I... company that identifies,develops and commercializ...today announced that posters describing research c...) will be presented at The 27th Annual,Scientific ...place May,8-10, 2008 in Tampa, Florida., The firs...
Other Biology Technology:Spectral and Toray expand collaboration to include new geographic territories 2Spectral and Toray expand collaboration to include new geographic territories 3Japan Patent Office Licenses GeneCards(R) from Xennex, Inc. 2Japan Patent Office Licenses GeneCards(R) from Xennex, Inc. 3Japan Patent Office Licenses GeneCards(R) from Xennex, Inc. 4YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING 2
(Date:11/4/2009)...n the cities of Long Beach and Riverside are respo... childhood asthma, and the true impact of air poll... been underestimated, according to researchers at ...The study, which appears in an online edition of t...that nine percent of all childhood asthma cases in...
(Date:11/4/2009)...a at Norman has received more than $10 million in ... of the federal stimulus program, bringing thetota...chers to $23 million. Thirty-three projects achie...aeology to weather. , "The university has though...g areasof scholarly excellence to federal agency p...
(Date:11/4/2009)...20 Aware, Inc. (Nasdaq: ...y and biometrics software, today reported financia...0, 2009. ,, Michael Tzannes, Aware,s Chairman..., we announced an agreement to sell our DSL and ho...ss semiconductor company being spun out of Infineo...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 1Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 2Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 3Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 4Brain Scans Could Help Spot Schizophrenia Earlier 56674 1Brain Scans Could Help Spot Schizophrenia Earlier 56674 2Leading Expert Available to Weigh in on Health Care Reform 56672 1Leading Expert Available to Weigh in on Health Care Reform 56672 2Leading Expert Available to Weigh in on Health Care Reform 56672 3
...arbara, Calif.) - It took a decade of painstaking ..., and a database of more than 200,000 fossil recor...he conventional wisdom about the diversity of mari...rcher with the National Center for Ecological Anal... the principal author of a report published in the...
...AA coral bleaching prediction system indicates tha...ter this year, but the event will probably not be ...bleaching outlook this week at the 11th Internatio... The system also suggests that there is a risk of... Islands in August, but little bleaching elsewhere...
...kins Ice Shelf is experiencing further disintegrat...idge connecting the shelf to Charcot Island. Since...helps to stabilise the ice shelf, it is likely the...the ice shelf at risk. , This animation, comprise...ic Aperture Radar (ASAR) between 30 May and 9 July...
Other Biology News:UCSB researcher leads worldwide study on marine fossil diversity 2New NOAA coral bleaching prediction system calls for low level of bleaching in Caribbean this year 2Wilkins Ice Shelf hanging by its last thread 2Wilkins Ice Shelf hanging by its last thread 3
... analytical to medium scale affinity purification ...vectors. Sufficient reagents are provided for puri... or denaturing conditions. Crude samples are incub...tains STag fusion proteins. After unbound proteins...
...ines deep experience, skills and flexibility in pr...orative team chemistry. This combination enables o...oval and beyond.,With AAIBiotech, you can cou...ou get more than that: its the power of team chemi...
Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.
Corning Proculture Spinner Flask,15L,Vertical S/Arm, No. Of S/A 4,Cent Neck 100mm from Sigma-Aldrich
Biology Products: